Crititech Particle Engineering Solutions, LLC
Lawrence, KS Part of Crititech, Inc.
- UEI
- QMLLX81RZ6V9
- CAGE
- 7UD60
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
-
- 325414 Biological Product (except Diagnostic) Manufacturing
- 325998 All Other Miscellaneous Chemical Product and Preparation Manufacturing
- 541713 Research and Development in Nanotechnology
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Corporate family
-
-
Parent
XT3PULKEW9K4
-
Parent
XT3PULKEW9K4
- SAM.gov registration date
- Physical address
- 1849 E 1450 Rd, Lawrence, KS 66044, USA
- Website
- crititech.com
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $140,595 |
| FY2025 | $67,593 |
| FY2024 | $109,996 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Defense Health Agency | $140,595 |
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Development of novel drug particles for inhalational therapy | Defense Health Agency | $140,595 | |
| Development of novel drug particles | Defense Health Agency | $67,593 | |
| Development of novel drug particles | Defense Health Agency | $109,996 |
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Fagron Sterile Services | Wichita, KS | 325412 Pharmaceutical Preparation Manufacturing |
| Mark Cuban Cost Plus Drug Company, PBC | Dallas, TX | 325412 Pharmaceutical Preparation Manufacturing |
| The Compounding Center Inc. | Phoenix, AZ | 424210 Drugs and Druggists' Sundries Merchant Wholesalers |
| U.s. Division | Rockville, MD | 424210 Drugs and Druggists' Sundries Merchant Wholesalers |
| Invisian Medical LLC | Prairie Village, KS | 423450 Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers |
About the company
Crititech Particle Engineering Solutions, LLC is a for-profit limited liability company based in Lawrence, Kansas, that specializes in the manufacture of goods, specifically in the field of pharmaceutical particle engineering. The company is registered with the federal government to receive contract and grant awards and maintains an active registration in SAM.gov through June 24, 2026. As a manufacturer focused on advancing particle engineering capabilities, Crititech provides specialized technical solutions that support the Department of Defense's medical and healthcare innovation objectives.
The company has demonstrated its capabilities through delivery order contracts awarded by the Defense Health Agency, the primary federal agency supporting its contract portfolio. Crititech was awarded two firm fixed-price delivery orders for the development of novel drug particles: the first valued at $109,995.75 with an award date of September 9, 2024, and an ultimate completion date of September 8, 2025, and the second valued at $67,592.51 awarded on July 1, 2025, with completion targeted for October 30, 2025. Both delivery orders represent work performed at the company's Lawrence, Kansas facility and were issued without small business set-aside designations. These contracts indicate that Crititech provides specialized pharmaceutical particle engineering services supporting the Defense Health Agency's medical innovation and healthcare support mission, with performance responsibilities retained entirely by Crititech and no major subcontractors identified in the award announcements.
Crititech holds a single-award Indefinite Delivery Contract (IDC) with the Defense Health Agency, established on September 9, 2024, with a ceiling value of $709,995.75 and a performance period extending through September 8, 2029. This IDC governs the development of novel drug particles and serves as the parent vehicle under which the company's delivery orders are issued. The contract structure demonstrates the Defense Health Agency's confidence in Crititech's capabilities and its intention to maintain an ongoing relationship for pharmaceutical particle engineering services over a multi-year period. With no set-aside designations applied, this IDC represents open competition contracting and positions Crititech as a primary resource for the Defense Health Agency's particle engineering requirements through 2029.
SBA capabilities narrative
Contract drug manufacturing organization capable of processing unique small particles for drug development and reformulation.
Quick answers
Is Crititech Particle Engineering Solutions, LLC registered in SAM.gov?
Yes. Crititech Particle Engineering Solutions, LLC's SAM.gov registration is active through June 18, 2027.
How much has Crititech Particle Engineering Solutions, LLC received in federal contracts?
Federal contracts obligated $67,593 to Crititech Particle Engineering Solutions, LLC in fiscal year 2025 and $318,184 in fiscal years 2023 through 2027.
What is Crititech Particle Engineering Solutions, LLC's most recent federal award?
Crititech Particle Engineering Solutions, LLC's most recent federal contract award is Development of novel drug particles for inhalational therapy (HT942526FE005), from Defense Health Agency, on December 3, 2025.
On GovTribe
See Crititech Particle Engineering Solutions, LLC's full federal record
- Federal contract awards
- IDV awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors